RAF1 and cancer: While B-Raf has the highest occurrence of mutations in human cancers and therefore appears to have a dominant role in the ERK signaling pathway, c-Raf, also known as Raf-1, has been the most extensively studied and thus is the best characterized Raf kinase [2].